This is the authors' abstract. We don't add key points for this paper.
The photoluminescence (PL) properties of metastable I‐III‐VI nanoparticles, such as the orthorhombic ( o ‐)AgInS 2 have suffered from the giant Stokes shifts, spectral broadening, and low PL quantum yield (PLQY) due to their large size and rich defect states. Herein, a novel one‐pot approach under atmospheric conditions was developed by heating the [Ag((C 4 H 9 ) 2 NCS 2 )] ([AgR]), [In((C 4 H 9 ) 2 NCS 2 ) 3 ] ([InR 3 ]) and zinc stearate (ZnSt 2 ) with molar ratio of 2:1:1 in 1‐dodecanethiol (DDT) and dodecane for the metastable o ‐AgInS 2 based nanostructures with intense, narrow and steady red PL emission. Such nanostructures exhibited relatively narrow full width at half maximum (FWHM) of 87 nm and high absolute PLQY of 53% at 659 nm among the reported o ‐AgInS 2 ‐based nanomaterials. The excellent PL property could be attributed to the high quality of the products without the Ag 2 S and surface oxidation. The growth mechanism was elucidated that the sequential decomposition of precursors with DDT led to the formation of amorphous Ag 2 S nanoparticles first, then the seeded growth mechanism led to the Ag 2 S‐AgInZn x S 2+ x heteronanostructrures, and finally led to the luminescent o ‐AgInS 2 ‐based nanostructures ( o ‐AgInS 2 ‐dominated nanoparticles and AgInS 2 ‐AgInZn x S 2+ x heteronanorods) and nonluminous Ag 2 S‐ o ‐AgInS 2 ‐AgInZn x S 2+ x heteronanoparticles, which were separated by centrifugation due to their different sizes, structures, and densities.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: